Genetic modification of T-cell clones for therapy of human viral and malignant diseases.

Philip D. Greenberg, Rosalynde J. Finch, Marc A. Gavin, Michael Kalos, Deborah A. Lewinsohn, Matthew Lonergan, James D. Lord, Brad H. Nelson, Claes Öhlén, Amy P. Sing,

PubMed · 1998 · 20 citations · 0 references

Concepts

Abstract

Our laboratory has pursued T cell therapy withantigen-specific T cell clones as means to treat humandisease. Our studies in the prevention of CMV disease